Survival According to Mutations in BRAF, KRAS, or Microsatellite Instability (MSI-H) after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Metastases from Colorectal Cancer.